An Innovative Microarray Strategy Identities Informative Molecular Markers for the Detection of Micrometastatic Breast Cancer
- 15 May 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (10) , 3697-3704
Abstract
There is increasing evidence that molecular detection of micrometastatic breast cancer in the axillary lymph nodes (ALN) of breast cancer patients can improve staging. Molecular analyses of samples obtained from the Minimally Invasive Molecular Staging of Breast Cancer Trial (n = 489 patients) indicate that whereas the majority of molecular markers are informative for the detection of metastatic breast cancer (significant disease burden), only a few are sensitive for the detection of micrometastatic disease (limited disease burden). Frequency distribution and linear regression analyses reveal that relative levels of gene expression are highly correlated with apparent sensitivity for the detection of micrometastic breast cancer (P < 0.05). These data provides statistical validation of the concept that the most informative markers for detection of micrometastatic disease are those that are most highly expressed in metastatic disease. To test this hypothesis, we developed an innovative microarray strategy. RNA from a metastatic breast cancer ALN was diluted into RNA from a normal lymph node and analyzed using Affymetrix microarrays. Expression analysis indicated that only two genes [mammaglobin (mam) and trefoil factor 1 (TFF1)] were significantly overexpressed at a dilution of 1:50. Real-time reverse transcription-PCR analysis of pathology-negative ALN (n = 72) confirm that of all the markers tested, mam and TFF1 have the highest apparent sensitivity for detection of micrometastatic breast cancer. We conclude that a dilutional microarray approach is a simple and reliable method for the identification of informative molecular markers for the detection of micrometastatic cancer.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- EpCAM Is Overexpressed in Breast Cancer and Is a Potential Target for Breast Cancer Gene TherapyCancer Research, 2004
- Molecular Detection of Micrometastatic Breast Cancer in Histopathology-Negative Axillary Lymph Nodes Correlates With Traditional Predictors of PrognosisAnnals of Surgery, 2004
- RT-PCR for Mammaglobin Genes,MGB1andMGB2, Identifies Breast Cancer Micrometastases in Sentinel Lymph NodesAmerican Journal of Clinical Pathology, 2004
- Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markersBritish Journal of Cancer, 2004
- Occult Axillary Lymph Node Metastases in Breast Cancer Do MatterAmerican Journal of Surgical Pathology, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- High Expression of the Trefoil Protein TFF1 in Interval Breast CancersThe American Journal of Pathology, 2001
- Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panelInternational Journal of Cancer, 2001
- Quantitative Gene Expression Analysis in Microdissected Archival Formalin-Fixed and Paraffin-Embedded Tumor TissueThe American Journal of Pathology, 2001
- Are Positive Axillary Nodes in Breast Cancer Markers for Incurable Disease?Annals of Surgery, 1993